369 related articles for article (PubMed ID: 20109107)
1. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
Ikenouchi-Sugita A; Yoshimura R; Okamoto T; Umene-Nakano W; Ueda N; Hori H; Katsuki A; Saito K; Tanaka Y; Nakamura J
World J Biol Psychiatry; 2010 Mar; 11(2):121-8. PubMed ID: 20109107
[TBL] [Abstract][Full Text] [Related]
2. Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus.
Ikenouchi-Sugita A; Yoshimura R; Hori H; Umene-Nakano W; Katsuki A; Saito K; Tanaka Y; Nakamura J
Hum Psychopharmacol; 2013 Mar; 28(2):198-202. PubMed ID: 23532751
[TBL] [Abstract][Full Text] [Related]
3. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
5. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
Sibbitt WL; Brandt JR; Johnson CR; Maldonado ME; Patel SR; Ford CC; Bankhurst AD; Brooks WM
J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
[TBL] [Abstract][Full Text] [Related]
6. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
[TBL] [Abstract][Full Text] [Related]
7. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
[TBL] [Abstract][Full Text] [Related]
10. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
[TBL] [Abstract][Full Text] [Related]
11. Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus.
Tamashiro LF; Oliveira RD; Oliveira R; Frota ER; Donadi EA; Del-Ben CM; Teixeira AL; Louzada-Junior P
Rheumatology (Oxford); 2014 Dec; 53(12):2182-90. PubMed ID: 24942492
[TBL] [Abstract][Full Text] [Related]
12. No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients.
Ikenouchi-Sugita A; Yoshimura R; Kishi T; Umene-Nakano W; Hori H; Katsuki A; Saito K; Iwata N; Tanaka Y; Nakamura J
Hum Psychopharmacol; 2011; 26(4-5):348-51. PubMed ID: 21678493
[TBL] [Abstract][Full Text] [Related]
13. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
14. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.
Kimura A; Kanoh Y; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Takemura M; Seishima M; Inuzuka T
Neurology; 2010 Apr; 74(17):1372-9. PubMed ID: 20421581
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
[TBL] [Abstract][Full Text] [Related]
16. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus.
Iikuni N; Okamoto H; Yoshio T; Sato E; Kamitsuji S; Iwamoto T; Momohara S; Taniguchi A; Yamanaka H; Minota S; Kamatani N
Ann Rheum Dis; 2006 Feb; 65(2):253-6. PubMed ID: 16410530
[TBL] [Abstract][Full Text] [Related]
17. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
Lu XY; Ye S; Wang Y; Guo L; Chen XX; Fan W; Wang XD; Gu YY; Bao CD; Liu Q
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2462-6. PubMed ID: 17156673
[TBL] [Abstract][Full Text] [Related]
19. Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus.
Roldan CA; Gelgand EA; Qualls CR; Sibbitt WL
J Clin Rheumatol; 2006 Feb; 12(1):3-10. PubMed ID: 16484873
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]